Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeted inhibition of genome-wide DNA methylation analysis in epigenetically modulated phenotypes in lung cancer.

Medical oncology (Northwood, London, England) - 1 Jun 2015

Dai Shou-Ping, Xie Chao, Ding Ning, Zhang Yi-Jun, Han Lei, Han Yun-Wei

Abstract excerpt

DNA methylation analysis, an epigenetic specification, has been explored for partial determination of cancer cell phenotypes. The development of metastasis in cancerogenesis has led its feasible association with the epigenetic modulations. We generated highly aggressive non-small cell lung cancer cell lines (HTB56 and A549) by using in vivo selection approach. These were, then, subjected to DNA methylation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimetabolites, Antineoplastic
Share to Azacitidine

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Carcinoma, Non-Small-Cell Lung

Share to Cell Line, Tumor

Share to DNA Methylation

Share to DNA Modification Methylases

Share to Epigenesis, Genetic

Share to Lung Neoplasms

Source

Identifiers

PMID: 25926333
DOI: 10.1007/s12032-015-0615-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeted inhibition of genome-wide DNA methylation analysis in epigenetically modulated phenotypes in lung cancer.PMID 25926333Read ↗

DNA methyltransferase inhibition reverses epigenetically embedded phenotypes in lung cancer preferentially affecting polycomb target genes.Semantic proximity Read ↗

Epigenetic therapy in non-small-cell lung cancer: targeting DNA methyltransferases and histone deacetylasesSemantic proximity Read ↗

Aberrant epigenetic regulation: a central contributor to lung carcinogenesis and a new therapeutic target.Semantic proximity Read ↗

DNA methylation and cancer.Semantic proximity Read ↗

Epigenetic Therapy of Non-Small Cell Lung Cancer Using Decitabine (5-Aza-2′-Deoxycytidine)Semantic proximity Read ↗

Azacytidine causes complex DNA methylation responses in myeloid leukemiaSemantic proximity Read ↗

Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.Semantic proximity Read ↗

Depletion of DNMT1 in differentiated human cells highlights key classes of sensitive genes and an interplay with polycomb repressionSemantic proximity Read ↗

Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung.Semantic proximity Read ↗

Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer.Semantic proximity Read ↗

Aberrant Gene Expression in Human Non Small Cell Lung Carcinoma Cells Exposed to Demethylating Agent 5-Aza-2'-DeoxycytidineSemantic proximity Read ↗

DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.